Resume-aware faculty matching

Find professors who actually fit you

Upload your resume. Four AI agents analyze your background, rank the faculty who fit, inspect their recent research, and help you draft outreach — grounded in their actual work, not templates.

Free to startNo credit cardCancel anytime
Top matches Balanced preset
Dr. Sarah Chen
Stanford · Interpretability · NLP
91
Dr. Marcus Holloway
MIT · Robotics · RL
84
Dr. Aisha Okonkwo
CMU · Fairness · HCI
82
Nova · Professor Researcher · re-ranking top 20…
Chris Jones

Chris Jones

· ESRR Professor of English

University of Utah · English

Active 1975–2024

h-index42
Citations11.8k
Papers18555 last 5y
Funding
See your match with Chris Jones — sign in to PhdFit.Sign in

Research topics

  • Medicine
  • Virology
  • Genetics
  • Biology
  • Immunology
  • Internal medicine
  • Demography
  • Pathology
  • Cell biology
  • Chemistry

Selected publications

  • SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

    Nature Microbiology · 2022 · 720 citations

    • Biology
    • Virology
    • Cell biology

    Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to COVID-19. The emergence of hypermutated, increasingly transmissible variants of concern (VOCs) threaten this strategy. Omicron (B.1.1.529), the fifth VOC to be described, harbours multiple amino acid mutations in spike, half of which lie within the receptor-binding domain. Here we demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273. These data were mirrored by a substantial reduction in real-world vaccine effectiveness that was partially restored by booster vaccination. The Omicron variants BA.1 and BA.2 did not induce cell syncytia in vitro and favoured a TMPRSS2-independent endosomal entry pathway, these phenotypes mapping to distinct regions of the spike protein. Impaired cell fusion was determined by the receptor-binding domain, while endosomal entry mapped to the S2 domain. Such marked changes in antigenicity and replicative biology may underlie the rapid global spread and altered pathogenicity of the Omicron variant.

  • Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

    Cell Reports · 2021 · 448 citations

    • Biology
    • Virology
    • Chemistry

    We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although ΔH69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. ΔH69/V70 is able to partially rescue infectivity of spike proteins that have acquired N439K and Y453F escape mutations by increased spike incorporation. In addition, replacement of the H69 and V70 residues in the Alpha variant B.1.1.7 spike (where ΔH69/V70 occurs naturally) impairs spike incorporation and entry efficiency of the B.1.1.7 spike pseudotyped virus. Alpha variant B.1.1.7 spike mediates faster kinetics of cell-cell fusion than wild-type Wuhan-1 D614G, dependent on ΔH69/V70. Therefore, as ΔH69/V70 compensates for immune escape mutations that impair infectivity, continued surveillance for deletions with functional effects is warranted.

  • Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

    The Lancet Public Health · 2021 · 343 citations

    • Medicine
    • Demography
    • Internal medicine

    BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We aimed to investigate whether increases in the proportion of infections with this variant are associated with differences in symptoms or disease course, reinfection rates, or transmissibility. METHODS: , for the two incidence estimates. FINDINGS: fell below 1 during regional and national lockdowns, even in regions with high proportions of infections with the B.1.1.7 variant. INTERPRETATION: The lack of change in symptoms identified in this study indicates that existing testing and surveillance infrastructure do not need to change specifically for the B.1.1.7 variant. In addition, given that there was no apparent increase in the reinfection rate, vaccines are likely to remain effective against the B.1.1.7 variant. FUNDING: Zoe Global, Department of Health (UK), Wellcome Trust, Engineering and Physical Sciences Research Council (UK), National Institute for Health Research (UK), Medical Research Council (UK), Alzheimer's Society.

  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

    Nature · 2021 · 713 citations

    • Virology
    • Biology
    • Medicine
  • SARS-CoV-2 evolution during treatment of chronic infection

    Nature · 2021 · 1076 citations

    • Virology
    • Biology
    • Immunology

Frequent coauthors

  • C. Hawkins

    University of Portsmouth

    600 shared
  • Stefan M. Pfister

    University Hospital Heidelberg

    540 shared
  • James T. Rutka

    Hospital for Sick Children

    540 shared
  • Darell D. Bigner

    Duke University

    525 shared
  • Diane K. Birks

    525 shared
  • R. Grundy

    Jilin University

    450 shared
  • Michael Handler

    UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik

    450 shared
  • N. Foreman

    450 shared

Similar researchers at University of Utah

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Chris Jones

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup